Mannatech,
Incorporated (NASDAQ: MTEX
- News),
a global pioneer in the development of high-quality health,
weight
and fitness, and skin
care solutions based on nutritional science, obtained a judgment
finding that Green Life, LLC (Green Life), and Xiong Lo (Lo)
infringed Mannatech patents (U.S. Patents 6,929,807;
7,157,431;
7,196,064;
7,199,104;
and 7,202,220).
Senior
United States District Judge A. Joe Fish in the U.S. District
Court for the Northern District of Texas, Dallas Division, issued a
final judgment that entered a broad permanent injunction against Green
Life and Lo prohibiting them from “making, using, offering to sell,
selling, or otherwise distributing within the United States, or
importing into the United States, defendant’s product, Glyco 8, as well
as products that are substantially equivalent in composition to Glyco 8,
and any other products that infringe the patents in suit.”
“This case underscores our commitment to pursuing injustice against the
company and our core technologies. We will continue to do what is
necessary to protect our intellectual property,” said Keith Clark,
Mannatech’s executive vice president and chief legal officer.
On July 15, Mannatech filed a complaint for patent infringement alleging
that Green Life and Xiong Lo infringed Mannatech’s patents entitled
“Compositions of Plant Technology as Dietary Supplements,” through Green
Life’s purchase of the dietary supplement Glyco 8 from defendant Boston
Mountain Laboratories, Inc. Mannatech also named Boston Mountain,
the entity that actually manufactured the infringing product, as a
defendant. Mannatech previously settled its claims against Boston
Mountain through the entry of an agreed final judgment that enjoined
Boston Mountain from manufacturing all products infringing on Mannatech
patents in question.
Mannatech offers a comprehensive approach to wellness that addresses
physical and financial health with cutting-edge, proprietary products
based on the foundation of nutritional science and business
opportunities for individuals around the world who seek purpose,
financial freedom and a chance to impact the lives of others. The
company has distinguished itself in the emerging glyconutrients market
through the development of Ambrotose® complex, the technology
for which it holds more than 45 patents in 30 countries. Glyconutrients
are dietary ingredients containing beneficial amounts of carbohydrates
which are believed to represent a new category of untapped vital
nutrients for proper nutrition.
Maternal fish consumption linked to lower likelihood of autism diagnosis, study finds